{"sourcedb":"DevicePMAs@therightstef","sourceid":"P100044_S001","text":"Approval for a shortened version of the drug-eluting sinus stent.  The device, as modified, will be marketed under the trade name propel mini sinus implant and is indicated for use in patients \u003E= 18 years of age following ethmoid sinus surgery to maintain patency, thereby reducing the need for post-operative intervention such as surgical adhesion lysis and/or use of oral steroids. the propel mini sinus implant separates mucosal tissues, provides stabilization of the middle turbinate, prevents obstruction by adhesions, and reduces edema.","project":"consensus_PMA_Age_Indications","denotations":[{"id":"T4","span":{"begin":199,"end":204},"obj":"age_start_unit"},{"id":"T3","span":{"begin":196,"end":198},"obj":"age_start"},{"id":"T2","span":{"begin":193,"end":195},"obj":"age_end"},{"id":"T1","span":{"begin":193,"end":204},"obj":"age_range"}]}